1. Home
  2. AMTD vs PMVP Comparison

AMTD vs PMVP Comparison

Compare AMTD & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMTD IDEA Group each representing six (6)

AMTD

AMTD IDEA Group each representing six (6)

N/A

Current Price

$0.83

Market Cap

71.2M

Sector

N/A

ML Signal

N/A

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

N/A

Current Price

$1.23

Market Cap

66.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMTD
PMVP
Founded
2003
2013
Country
France
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.2M
66.1M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
AMTD
PMVP
Price
$0.83
$1.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.2K
290.1K
Earning Date
04-29-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$1.02
52 Week High
$1.65
$1.88

Technical Indicators

Market Signals
Indicator
AMTD
PMVP
Relative Strength Index (RSI) 41.56 49.82
Support Level $0.71 $1.04
Resistance Level $0.80 $1.26
Average True Range (ATR) 0.04 0.06
MACD 0.01 0.00
Stochastic Oscillator 29.95 26.67

Price Performance

Historical Comparison
AMTD
PMVP

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a diversified institution and digital solutions conglomerate group, connecting companies and investors with world-wide markets. The group operates its businesses in five reportable and operating segments: capital market solutions segment, digital solutions and other services segment, media and entertainment segment, hotel operations, hospitality and VIP services segment, and strategic investment segment. The group generates the majority of its revenue from the strategic investment segment that engages in proprietary investments and management of world-wide investment portfolio (including listed and unlisted equity shares investments and movie rights investments). Its geographic areas are China, Europe, America, and Southeast Asia.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: